Sertraline in the treatment of women with postpartum major depression
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
No consensus has yet been reached as to whether or not postpartum depression (PPD) represents a distinct clinical entity. Despite the increasing evidence that gender differences may exist in antidepressant treatment response, there is an absence of studies in women with postpartum onset of major depression. The aim of this study was to assess the clinical efficacy of the selective serotonin reuptake inhibitor (SSRI), sertraline, in the treatment of women with a major depressive episode (MDE) that occurred within 6 months of childbirth using an 8 week, prospective, open‐labelled design. Further, we sought to determine if the Edinburgh Postnatal Depression Scale (EPDS) was a useful instrument to monitor the clinical response to drug treatment. Twenty‐six postpartum women who fulfilled DSM‐IIIR criteria for major depressive episode, non‐psychotic, with symptom onset within 6 months postpartum were enrolled in the study. Biweekly assessments included physician and self‐rated depression measures. Twenty‐one of the women (81%) completed the 8 week study; 20 women exhibited a salutary response as defined by > 50% reduction from baseline in SIGH‐D scores (mean reduction = 15.7 points). Fourteen women demonstrated complete symptom remission with recovery of function (SIGH‐D < 7, CGI = 1, GAP > 80) upon completion of the 8 week study. Three women experienced significant side effects; these included gastrointestinal disturbance (n =1) and anorgasmia (n = 2). Our results indicate that: (1) sertraline is a highly efficacious and well‐tolerated treatment for women with postpartum depression; (2) the EPDS is comparable to the BDI and SIGH‐D for monitoring treatment response in women with postpartum onset MDE; (3) PPD (MDE onset within 4 weeks postpartum, as defined by DSM IV) required significantly less medication and tended to respond faster than MDE onset after 4 weeks postpartum; and (4) the rapid response rate underscores the need to conduct placebo‐controlled studies in this population. Depression 3:49–55 (1995). © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115
Cited by
Wisner, K. L., Parry, B. L., & Piontek, C. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011542 · Cited by 666
Psychosocial and psychological interventions for treating postpartum depression
Dennis, C.-L., & Hodnett, E. D. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006116.pub2 · Cited by 565
Hormones and mood: from menarche to menopause and beyond
Steiner, M. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00432-9 · Cited by 558
A meta-analysis of treatments for perinatal depression
Sockol, L. E., Epperson, C. N., & Barber, J. P. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.03.009 · Cited by 287
Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?
Joffe, H., & Cohen, L. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00169-3 · Cited by 283
Metadata
- Authors
- Stowe, Z. N., Casarella, J., Landry, J., & Nemeroff, C. B.
- Venue
- Depression
- Publisher
- Wiley
- Published
- 1995-01
- Volume
- 3
- Issue
- 1-2
- Pages
- 49-55
- ISSN
- 1062-6417 (ISSN-L)
- 1522-7162
- OpenAlex
- W2005378805
- Cited by
- 95
- References
- 1
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sertraline in the treatment of women with postpartum major depression. https://app.cochat.ai/papers/10.1002/depr.3050030109
- The paper
- Stowe, Z. N., Casarella, J., Landry, J., & Nemeroff, C. B. (1995). Sertraline in the treatment of women with postpartum major depression. Depression. https://doi.org/10.1002/depr.3050030109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.